Manecke Gerard R
UCSD Medical Center, 200 West Arbor Drive, San Diego, CA 92103, USA.
Expert Rev Med Devices. 2005 Sep;2(5):523-7. doi: 10.1586/17434440.2.5.523.
Edwards Lifesciences has recently introduced the FloTrac sensor and Vigileo monitor system for monitoring cardiac output continuously. It does not require thermodilution or dye dilution, but rather bases its calculations on arterial waveform characteristics in conjunction with patient demographic data. It is unique among arterial waveform cardiac output systems in that it does not require calibration with another method. Studies thus far indicate that it is robust and accurate over a wide range of cardiac output and clinical conditions. It will be valuable in the care of many patients, such as those with critical illness, cardiovascular dysfunction, trauma or undergoing major surgery.
爱德华兹生命科学公司最近推出了用于持续监测心输出量的FloTrac传感器和Vigileo监测系统。它不需要热稀释法或染料稀释法,而是结合患者人口统计学数据,根据动脉波形特征进行计算。在动脉波形心输出量系统中,它的独特之处在于不需要用另一种方法进行校准。迄今为止的研究表明,在广泛的心输出量范围和临床条件下,它都很可靠且准确。它对于许多患者的护理将很有价值,比如患有危重病、心血管功能障碍、创伤或正在接受大手术的患者。